Current Drug Discovery Technologies

Vladimir P. Torchilin
Department of Pharmaceutical Science Center
for Pharmaceutical Biotechnology and Nanomedicine
Northeastern University
Boston, MA 02115



Become EABM
Become Reviewer

Antisense Antibiotics: A Brief Review of Novel Target Discovery and Delivery

Volume:7   Issue: 2
Pp: 76-85
Hui Bai, Xiaoyan Xue, Zheng Hou, Ying Zhou, Jingru Meng and Xiaoxing Luo
DOI: 10.2174/157016310793180594

Functional Gene Discovery Using RNA Interference-Based Genomic Screens to Combat Pathogen Infection

Volume:7   Issue: 2
Pp: 86-94
Elizabeth Hong-Geller and Sofiya N. Micheva-Viteva
DOI: 10.2174/157016310793180657

Versatile Applications of microRNA in Anti-Cancer Drug Discovery: From Therapeutics to Biomarkers

Volume:7   Issue: 2
Pp: 95-105
Haruhisa Iguchi, Nobuyoshi Kosaka and Takahiro Ochiya
DOI: 10.2174/157016310793180648

Preparation and Evaluation of Famotidine Polymorphs

Volume:7   Issue: 2
Pp: 106-116
Ravouru Nagaraju, Ande Penchala Prathusha, Penjury Subhash Chandra Bose, Rajesh Kaza3 and Koganti Bharathi
DOI: 10.2174/157016310793180639

Nanoemulsion Encapsulation and In Vitro SLN Models of Delivery for Cytotoxic Methotrexate

Volume:7   Issue: 2
Pp: 123-136
Cormac Concannon, Desmond A. Hennelly, Simon Noott and Dipak K. Sarker
DOI: 10.2174/157016310793180620

Human Kallikrein 6 Cerebrospinal Levels are Elevated in Multiple Sclerosis

Volume:7   Issue: 2
Pp: 137-140
Andrea L.O. Hebb, Virender Bhan, Alexander D. Wishart, Craig S. Moore and George S. Robertson
DOI: 10.2174/157016310793180611